Skip to main content
. 2018 May 1;9(33):22886–22894. doi: 10.18632/oncotarget.25094

Table 1. Summary of cases included in the study.

Case Gender Age Ethnicity Treatment Relapse SG (months) KIT
1 Female 69 White CX + RXT Yes 117 Wild
2 Female 66 White CX + RXT Yes 54 Wild
3 Female 38 White CX Yes 11 Wild
4 Female 88 White CX + RXT Yes Still Alive Wild
5 Female 64 White CX + RXT No Still Alive Mutated
6 Female 61 White CX + RXT No Still Alive Wild
7 Female 62 White CX + RXT Yes 27 Wild
8 Female 62 White CX Yes 29 Wild
9 Female 39 White CX + RXT Yes Still Alive Wild
10 Female 62 White CX No Still Alive Wild
11 Female 27 White CX Yes 10 Wild
12 Female 59 White CX Yes Still Alive Wild
13 Female 60 White CX Yes 8 Wild
14 Female 76 White CX Yes 11 Wild
15 Female 63 White CX Yes 14 Wild
16 Female 69 White CX Yes 14 Wild
17 Male 32 White CX + RXT Yes 19 Wild
18 Male 85 White CX + RXT Yes 43 Wild
19 Male 47 White CX No Still Alive Wild
20 Male 39 White CX + RXT Yes 64 Wild
21 Male 53 White CX + RXT Yes 99 Mutated
22 Male 52 White CX + RXT Yes Still Alive Mutated
23 Male 62 White CX + RXT Yes 27 Wild
24 Male 51 White CX + RXT No Still Alive Wild
25 Male 40 White CX + RXT Yes 15 Mutated
26 Male 81 Black CX Yes 60 Mutated
27 Male 69 Black CX + RXT Yes 21 Mutated
28 Male 76 Black CX + RXT Yes 11 Mutated

CX + RXT = Surgical resection followed by adjuvante radiotherapy, CX = Exclusive surgical resection, OS = Overall survival.